{"id":"4a6cb329-1e74-4c96-aa13-801a48a13d99","companyId":"12386361-d374-4da6-9fc4-81aacf34e7db","modelName":"Ultrahuman Ring (Air / Pro)","slug":"ultrahuman-ring-air","description":"Ultrahuman, founded in 2019 in Bengaluru, India by Mohit Kumar and Vatsal Singhal, both previously of Runnr, makes the Ring Air and the newer Ring Pro biometric smart rings, recorded in the biometric form factor, on a Series B of $35 million at roughly a $125 million valuation in March 2024 with a strong India-market base and global availability. Its rings pair heart-rate, heart-rate-variability, temperature, sleep, and recovery sensing with modular PowerPlugs for metabolic and circadian insights and a paid atrial-fibrillation plug, with no mandatory subscription for core tracking. It is the load-bearing verified-versus-claimed exemplar at company-availability scope: in Oura's International Trade Commission case over patent 11,868,178, a final determination around August 22, 2025 found all asserted claims valid and infringed by Ultrahuman, issuing a limited exclusion order and cease-and-desist orders that took effect on October 21, 2025 after the sixty-day Presidential review concluded without a veto, and Ultrahuman's appeal to the Federal Circuit is pending with its emergency stay denied by both the ITC and the court, so its Ring Air's US market access was legally blocked even though the product and its AI exist and ship globally. Ultrahuman re-entered the US not via Texas-made Ring Airs but via a redesigned Ring Pro whose unibody architecture is engineered so the patent does not apply, clearing US Customs around March 24, 2026 and reopening US pre-orders, so the Ring Air is recorded as US-excluded with an appeal pending while the Ring Pro is US-available. On FDA status, its atrial-fibrillation detection is powered by the third-party FDA-cleared FibriCheck software whose vendor holds the clearance rather than Ultrahuman's ring, gated behind a paid plug, so headlines calling the ring FDA-approved overstate it, and its cumulative funding figures beyond the verified Series B and its self-published validation studies are not independently verified. A correction worth recording: the co-founder is Vatsal Singhal, not Vatsal Kumar.","formFactor":"biometric","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"notes":[{"label":"Verified","value":"Ultrahuman (founded 2019, Bengaluru; co-founders Mohit Kumar + Vatsal Singhal, ex-Runnr) makes the Ring Air + Ring Pro. Series B $35M at ~$125M valuation (Mar 2024; Blume/Steadview/Nexus/Alpha Wave + Zomato's Deepinder Goyal). Strong India-market base + global availability. maturity=commercial / scaling. CORRECTION: co-founder is Vatsal SINGHAL (not 'Vatsal Kumar')."},{"label":"ITC EXEMPLAR (company-availability-scope disabled pattern)","value":"Oura's ITC case (337-TA-1398, Patent 11,868,178 - a layered internal-component structure): final determination ~Aug 22 2025 (announced Sept 9), upheld - all asserted claims valid + infringed by Ultrahuman; LIMITED EXCLUSION ORDER + cease-and-desist; effective Oct 21 2025 after the 60-day Presidential review (no veto). Ultrahuman appealed to the Federal Circuit (filed ~Oct 22 2025); BOTH the ITC + Federal Circuit DENIED the emergency stay; appeal on the merits PENDING. This is a verified-vs-claimed exemplar at COMPANY-AVAILABILITY scope (product + AI exist + ship globally; US market access legally BLOCKED for the Ring Air)."},{"label":"US re-entry (corrects the 'Texas-made' framing)","value":"Ultrahuman re-entered the US NOT via Texas-made Ring Airs but via a REDESIGNED Ring Pro: its unibody metal architecture was engineered so the '178 patent does not apply; the Ring Pro cleared US Customs (CBP) ~Mar 24 2026 and reopened US pre-orders ($349-399). Record: Ring Air = US-EXCLUDED (active order, appeal pending); Ring Pro = US-AVAILABLE (redesigned)."},{"label":"FDA + cap-flag","value":"AFib detection is powered by third-party FDA-cleared FibriCheck tech (the ALGORITHM VENDOR holds the clearance, not Ultrahuman's ring), gated behind a paid plug; the ring is otherwise general-wellness. 'Ultrahuman ring is FDA-approved' headlines OVERSTATE it. NOT verified: cumulative ~$103M / ~$120M WestBridge raise (aggregator/'in talks' - only $35M/$125M Series B firm); self-published validation studies are vendor-run, not independent clearance."}],"specs":"Ring Air (HR/HRV/temp/sleep/recovery) + Ring Pro (global ~Feb 2026; 15-day battery; ~$349-399). AI via modular 'PowerPlugs' (metabolic/cardio adaptability, circadian rhythm, caffeine window, AFib, cycle). No MANDATORY subscription for core tracking; some premium PowerPlugs paid (AFib ~$4.90/mo). Founded 2019, Bengaluru India (founders Mohit Kumar (CEO) + Vatsal Singhal); + Plano TX factory. Series B $35M at ~$125M (Mar 2024).","formFactor":"biometric (biometric-primary smart ring + AI augmentation; metabolic/circadian/recovery)"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Ultrahuman","title":"Ultrahuman (founded 2019, Bengaluru; founders Mohit Kumar + Vatsal Singhal; Ring Air)","sourceName":"Wikipedia"},{"url":"https://www.businesswire.com/news/home/20250909387922/en/","title":"ITC final determination (Oura v Ultrahuman/RingConn; Patent 11,868,178; limited exclusion order)","sourceName":"Oura (Business Wire)"},{"url":"https://techcrunch.com/2026/03/24/ultrahuman-ramps-up-u-s-push-with-ring-pro-as-oura-tightens-grip/","title":"Ultrahuman Ring Pro (redesigned unibody, avoids '178) cleared US Customs ~Mar 24 2026; US pre-orders reopened","sourceName":"TechCrunch"},{"url":"https://longevity.technology/news/ultrahuman-launches-atrial-fibrillation-detection-via-smart-ring/","title":"Ultrahuman AFib detection via FDA-cleared FibriCheck (third-party); paid PowerPlug (~$4.90/mo)","sourceName":"Longevity.Technology"}],"aliases":["Ultrahuman Ring Air","Ultrahuman Ring Pro","Ultrahuman M1"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-03T22:46:04.957Z","updatedAt":"2026-06-03T22:46:04.957Z","jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/ultrahuman-ring-air","url":"https://registry.deploy.report/models/ultrahuman-ring-air","name":"Ultrahuman Ring (Air / Pro)","alternateName":["Ultrahuman Ring Air","Ultrahuman Ring Pro","Ultrahuman M1"],"description":"Ultrahuman, founded in 2019 in Bengaluru, India by Mohit Kumar and Vatsal Singhal, both previously of Runnr, makes the Ring Air and the newer Ring Pro biometric smart rings, recorded in the biometric form factor, on a Series B of $35 million at roughly a $125 million valuation in March 2024 with a strong India-market base and global availability. Its rings pair heart-rate, heart-rate-variability, temperature, sleep, and recovery sensing with modular PowerPlugs for metabolic and circadian insights and a paid atrial-fibrillation plug, with no mandatory subscription for core tracking. It is the load-bearing verified-versus-claimed exemplar at company-availability scope: in Oura's International Trade Commission case over patent 11,868,178, a final determination around August 22, 2025 found all asserted claims valid and infringed by Ultrahuman, issuing a limited exclusion order and cease-and-desist orders that took effect on October 21, 2025 after the sixty-day Presidential review concluded without a veto, and Ultrahuman's appeal to the Federal Circuit is pending with its emergency stay denied by both the ITC and the court, so its Ring Air's US market access was legally blocked even though the product and its AI exist and ship globally. Ultrahuman re-entered the US not via Texas-made Ring Airs but via a redesigned Ring Pro whose unibody architecture is engineered so the patent does not apply, clearing US Customs around March 24, 2026 and reopening US pre-orders, so the Ring Air is recorded as US-excluded with an appeal pending while the Ring Pro is US-available. On FDA status, its atrial-fibrillation detection is powered by the third-party FDA-cleared FibriCheck software whose vendor holds the clearance rather than Ultrahuman's ring, gated behind a paid plug, so headlines calling the ring FDA-approved overstate it, and its cumulative funding figures beyond the verified Series B and its self-published validation studies are not independently verified. A correction worth recording: the co-founder is Vatsal Singhal, not Vatsal Kumar.","identifier":"4a6cb329-1e74-4c96-aa13-801a48a13d99","category":"biometric","publisher":{"@id":"https://deploy.report/#organization"}}}